SPACInsider Logo
Healthcare Capital Corp. (HCCC) Shareholders Approve Alpha Tau Deal
by Nicholas Alan Clayton on 2022-02-22 at 8:36am

Healthcare Capital Corp. (NASDAQ:HCCC) announced this morning that its shareholders have voted to approve its combination with Alpha Tau Medical, but has not given any hints as to its redemption figures.

The SPAC adjourned its special meeting to complete the deal twice last week, noting that not all closing conditions were satisfied.  Healthcare Capital announced significant concessions to its sponsor economics on the eve of the final vote including a forfeiture of 4,709,375 promote shares and 4,658,000 private placement shares.

Alpha Tau’s shares and warrants are expected to begin trading on the Nasdaq under the symbols “DRTS” and “DRTSW”, respectively, once the transaction is closed. It is up in premarket trading with a bid/ask around $10.60/$11.09 up from the SPAC’s last close at $10.08, which could indicate some traders feeling out a “low float” situation. But, even if it would meet such criteria, Nasdaq has recently shown its readiness to intervene in such scenarios, as it did in suspending Inspirato (NASDAQ:ISPO) following its high-redemption de-SPAC.

Healthcare Capital originally announced its $650 million deal with Alpha Tau last summer on July 8. Jerusalem-based Alpha Tau is developing unique cancer treatments that utilize alpha radiation to attack tumors with reduced damage to surrounding tissues and cells.


ADVISORS

  • Citigroup is acting as financial advisor to Alpha Tau.
  • Citigroup, Piper Sandler, and Cantor Fitzgerald are acting as joint placement agents on the PIPE.
  • Cantor Fitzgerald is acting as a capital markets advisor to HCC.
  • Value Base M&A Ltd. is also acting as financial advisor on the transaction.
  • Latham & Watkins LLP and Meitar | Law Offices are acting as legal advisors to Alpha Tau.
  • Ellenoff Grossman & Schole LLP and FBC & Co. are acting as legal advisors to HCC.
  • Winston & Strawn LLP is acting as legal advisor to the placement agents.
Recent Posts
by Sam Beattie on 2022-12-02 at 7:10pm

Terms Tracker for the Week Ending December 2nd, 2022 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. As we slide into December, and the holiday season, we recognized two new S-1 registration statements and zero IPOs. The two new S-1s consisted of...

by Marlena Haddad on 2022-12-02 at 5:38pm

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC Liquidations: NightDragon, VectoIQ II, and Fortistar Sustainable Solutions Corp. Night Dragon Acquisition Corp. Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination NightDragon Acquisition Corp. (NASDAQ: NDAC) anticipates that the last trading day...

by Marlena Haddad on 2022-12-02 at 4:38pm

Lakeshore Acquisition I Corp. (NASDAQ:LAAA) disclosed this afternoon that its shareholders have approved its business combination with medical device company ProSomnus during a special meeting held earlier today. Approximately 92.4% of the votes cast at the meeting on the business combination proposal, representing approximately 80.5% of Lakeshore’s outstanding shares, voted to approve the deal. The SPAC disclosed...

by Marlena Haddad on 2022-12-02 at 11:38am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: Embark director Elaine Chao and others sued over SPAC merger, Alvotech switches CEO and takes COO from Teva, and Uber Freight and Aurora expand pilot  Embark Director Elaine Chao, Others Sued Over SPAC...

by Nicholas Alan Clayton on 2022-12-02 at 7:51am

SPACInsider contributors Anthony Sozzi and Sam Beattie this week compiled their three favorite potential SPAC targets among potential targets in the security industry. We look at why they are compelling and why each could be a fit for a blank-check merger. Security is on the market’s mind and is expected to grow at a CAGR...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved